EVOGENE LTD (EVGN)
IL0011050551 - Common Stock
EVOGENE LTD
NASDAQ:EVGN (11/1/2024, 8:00:02 PM)
After market: 2.18 -0.06 (-2.68%)2.24
-0.04 (-1.75%)
Company Profile
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Company Info
EVOGENE LTD
13 Gad Feinstein Street, Park Rehovot
Rehovot 7414002
P: 97289311900
CEO: Ofer Haviv
Employees: 142
Website: https://evogene.com/
EVGN News
3 days ago - ChartmillThe trading volume of these stocks is deviating from the norm in today's session.The trading volume of these stocks is deviating from the norm in today's session.
6 days ago - Casterra Ag Ltd.Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company for oil production for bio-based products and biofuel, and a...
a month ago - Lavie BioLavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), announced receiving a grant from...
2 months ago - EvogeneEvogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement/PRNewswire/ -- Evogene Ltd. ("Evogene" or the "Company") (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize...
2 months ago - BusinessInsiderEVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evogene (NASDAQ:EVGN) just reported results for the second quarter of 2024.Evog...
2 months ago - InvestorPlaceEVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
EVGN Twits
Here you can normally see the latest stock twits on EVGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
